Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong · Delayed Price · Currency is HKD 107.20
+3.00 (2.88%)
Nov 10, 2026, 4:08 PM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 9.71 billion as of November 9, 2026. It is the 8,941st most valuable company in the world and the 446th biggest in Hong Kong. Its market cap has decreased by 61.43% in one year.
Market Cap
9.71B
Enterprise Value
6.63B
Revenue
972.22M
Global Rank
Country Rank
#446 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has decreased from 17.51B to 9.71B, a decrease of -44.58%. That is a compound annual growth rate of -31.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 9.71B | -63.60% |
| Dec 31, 2025 | 26.66B | 52.24% |
| Apr 15, 2025 | 17.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Metis TechBio | 13.16B |
| Ascentage Pharma Group International | 10.98B |
| Everest Medicines | 9.20B |
| HBM Holdings | 8.87B |
| CStone Pharmaceuticals | 8.61B |
| GenFleet Therapeutics (Shanghai) | 8.34B |
| Shaanxi Micot Pharmaceutical Technology | 8.10B |
| Suzhou Ribo Life Science | 7.36B |